Paragangliomas of the head and neck: a contemporary review

in Endocrine Oncology
Authors:
Nathan J. GrahamN Graham, Department of Otolaryngology-Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, United States

Search for other papers by Nathan J. Graham in
Current site
Google Scholar
PubMed
Close
,
Joshua D. SmithJ Smith, Department of Otolaryngology-Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, United States

Search for other papers by Joshua D. Smith in
Current site
Google Scholar
PubMed
Close
,
Tobias ElseT Else, Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, United States

Search for other papers by Tobias Else in
Current site
Google Scholar
PubMed
Close
, and
Greg J. BasuraG Basura, Department of Otolaryngology-Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, United States

Search for other papers by Greg J. Basura in
Current site
Google Scholar
PubMed
Close

Correspondence: Tobias Else, Email: telse@med.umich.edu
Open access

Head and neck paragangliomas are slow-growing, vascular, typically benign tumors whose growth may induce significant lower cranial nerve deficits. While most tumors arise sporadically, a significant portion are associated with defined genetic syndromes. While surgical resection has historically been the gold standard, management strategies have evolved with acknowledgement of high surgical morbidity, slow tumor growth rates, and technological advances. Conservative management approaches via observation and newer radiation therapy techniques have become more common. This review seeks to provide an update on contemporary management strategies for head and neck paragangliomas and future directions.

 

  • Collapse
  • Expand

Society for Endocrinology logo